7UJY
Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time
Replaces: 6VPKSummary for 7UJY
Entry DOI | 10.2210/pdb7ujy/pdb |
Descriptor | Estrogen receptor, (5R,6S)-5-(4-{2-[(2R)-2-methylpyrrolidin-1-yl]ethoxy}phenyl)-6-phenyl-5,6,7,8-tetrahydronaphthalen-2-ol (3 entities in total) |
Functional Keywords | estrogen receptor alpha, drug resistance, breast cancer, alp helical bundle, antiestrogen, serm, transcription |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 4 |
Total formula weight | 122299.06 |
Authors | Hosfield, D.J.,Greene, G.L.,Fanning, S.W. (deposition date: 2022-03-31, release date: 2022-06-15, Last modification date: 2023-10-18) |
Primary citation | Hosfield, D.J.,Weber, S.,Li, N.S.,Suavage, M.,Joiner, C.F.,Hancock, G.R.,Sullivan, E.A.,Ndukwe, E.,Han, R.,Cush, S.,Laine, M.,Mader, S.C.,Greene, G.L.,Fanning, S.W. Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. Elife, 11:-, 2022 Cited by PubMed: 35575456DOI: 10.7554/eLife.72512 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.7 Å) |
Structure validation
Download full validation report